Sign Up for Free!

Continue Analyzing the page and more.

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

GUIDED THERAPEUTICS INC logo

GUIDED THERAPEUTICS INC

US$0.19

US$14.2m

-5.00%

69.49%

Dashboard Funda..tals Deep..lue Prediction Screener Map

GUIDED THERAPEUTICS INC Overview

Industry: Medical Devices

Sector: Healthcare

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.

GUIDED THERAPEUTICS INC is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.

Score

Price History & Performance

Review GUIDED THERAPEUTICS INC in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.

Recent News



GUIDED THERAPEUTICS INC Competitors

GUIDED THERAPEUTICS INC operates in the Medical Devices industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.

Earnings Per Share

EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.

Continue the analysis

Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.

View plans
Ticker Image

GUIDED THERAPEUTICS INC

US$0.19

US$14.2m

-5.00%

69.49%